QuidelOrtho (QuidelOrtho) Risk Assessment

View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of QuidelOrtho is: High Risk: Sensitive to economic or industry trends.

Competitive Comparison of QuidelOrtho's Risk Assessment

For the Medical Devices subindustry, QuidelOrtho's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QuidelOrtho's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Risk Assessment distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Risk Assessment falls into.

QuidelOrtho (NAS:QDEL) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

QuidelOrtho Risk Assessment Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

QuidelOrtho (QuidelOrtho) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

QL1A:Germany

Address

9975 Summers Ridge Road, San Diego, CA, USA, 92121

Website

https://www.quidelortho.com

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Executives

Louise Brandy	officer: SVP, Chief Information Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein	officer: Chief Administrative Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith	director	125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael	director	618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy	officer: SVP, Cardio/Metabolic Unit	9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll	officer: SVP, Research and Development	12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler	director
Robert R. Schmidt	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli	officer: SVP, Molecular Bus. Unit	9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski	officer: See Remarks	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr.	director	82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges	officer: SVP, General Counsel	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant	director, officer: Chairman & CEO	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky	officer: Chief Financial Officer	1717 DEERFIELD ROAD, DEERFIELD IL 60015